Predicting drug-metagenome interactions: Variation in the microbial β-glucuronidase level in the human gut metagenomes

Abstract excerpt

Characterizing the gut microbiota in terms of their capacity to interfere with drug metabolism is necessary to achieve drug efficacy and safety. Although examples of drug-microbiome interactions are well-documented, little has been reported about a computational pipeline for systematically identifying and characterizing bacterial enzymes that process particular classes of drugs. The goal of our study is to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biochemical Analysis and Sensing Techniques
• Share to Diet and metabolism studies
• Share to Gut microbiota and health